Watch Ticker

Reviva Pharmaceuticals Holdings, Inc. Warrants

Go to Reviva Pharmaceuticals Holdings, Inc. Warrants Website

$0.03

0.00 (-0.33%)

Live

Previous Close

$0.0305

Day Range

$0.0305 - $0.0306

Previous Day Range

$0.0305 - $0.0347

Market Cap

$ USD

Day Vol.

6639

Previous Day Vol.

115099

Currency

USD

Primary Exchange

Nasdaq

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and ca...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - Schizophrenia Market to Witness Significant Growth by 2034 Across 7MM as New Therapies Enter Late-Stage Trials | DelveInsight

The schizophrenia market is expected to grow significantly by 2034, driven by rising disease prevalence, expanding approved therapies, and the anticipated launch of new treatments such as Olanzapine LAI, Iclepertin, Ulotaront, and Brilaroxazine.

Related tickers: TEVA, RVPH, RVPHW, NERV.

Read Full Article

N/A - Reviva to Participate in the 2025 BIO CEO & Investor Conference

Reviva Pharmaceuticals Holdings, Inc. (RVPH), a late-stage pharmaceutical company, announced that its Founder, President, and CEO will participate in a panel discussion at the 2025 BIO CEO & Investor Conference, focusing on tackling mental health through new targets and endpoints progress.

Related tickers: RVPH, RVPHW.

Read Full Article

Trending Tickers

Please sign in to view